1. Home
  2. ASTI vs LITS Comparison

ASTI vs LITS Comparison

Compare ASTI & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$2.14

Market Cap

30.0M

Sector

Technology

ML Signal

HOLD

LITS

Lite Strategy Inc.

SELL

Current Price

$1.22

Market Cap

25.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASTI
LITS
Founded
2005
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
25.7M
IPO Year
2014
2003

Fundamental Metrics

Financial Performance
Metric
ASTI
LITS
Price
$2.14
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
254.9K
★ 930.1K
Earning Date
11-09-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 70.23
13.81
EPS
★ N/A
N/A
Revenue
★ $10,398,149.00
N/A
Revenue This Year
$987.62
N/A
Revenue Next Year
$2,579.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 163.25
N/A
52 Week Low
$1.40
$0.69
52 Week High
$9.87
$2.26

Technical Indicators

Market Signals
Indicator
ASTI
LITS
Relative Strength Index (RSI) 30.14 49.21
Support Level N/A $1.06
Resistance Level $3.22 $1.25
Average True Range (ATR) 0.19 0.11
MACD -0.03 -0.02
Stochastic Oscillator 5.86 13.51

Price Performance

Historical Comparison
ASTI
LITS

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About LITS Lite Strategy Inc.

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Share on Social Networks: